ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
PDYN
Palladyne AI Corp.
There isn't enough reported data to score PDYN yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
PDYN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
PDYN's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
PDYN PE Valuation
PDYN has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
PDYN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect PDYN's losses to grow, with revenue growing.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
PDYN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.82 | +$0.88 |
| Q2 2026 | -$0.66 | +$1.22 |
| Q1 2026 | -$0.59 | +$1.29 |
| Q4 2025 | $0.24 | +$2.95 |
| Q3 2025 | -$1.70 | +$1.17 |
| Q2 2025 | -$1.88 | +$1.85 |
| Q1 2025 | -$1.88 | +$2.77 |
| Q4 2024 | -$2.71 | +$2.50 |
PDYN has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over PDYN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
PDYN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.6M | +895% |
| Q2 2026 | $5.8M | +470% |
| Q1 2026 | $3.5M | +107% |
| Q4 2025 | $1.7M | +118% |
| Q3 2025 | $860K | -1.3% |
| Q2 2025 | $1M | -63% |
| Q1 2025 | $1.7M | -50% |
| Q4 2024 | $761K | +2% |
PDYN's revenue has grown year over year for four quarters in a row: $9M last quarter, up 895% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -156% | +781 points |
| Q2 2026 | -232% | +566 points |
| Q1 2026 | -337% | +68 points |
| Q4 2025 | -561% | +291 points |
| Q3 2025 | -938% | -100 points |
| Q2 2025 | -797% | -584 points |
| Q1 2025 | -405% | -192 points |
| Q4 2024 | -852% | +4115 points |
PDYN has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
PDYN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.7M | -$2M |
| Q2 2026 | -$11M | -$5.7M |
| Q1 2026 | -$10.3M | -$2.7M |
| Q4 2025 | -$8.7M | -$3.6M |
| Q3 2025 | -$6.7M | -$2.2M |
| Q2 2025 | -$5.3M | +$614K |
| Q1 2025 | -$7.6M | -$311K |
| Q4 2024 | -$5.1M | +$11.1M |
PDYN has the edge over ASTS on cash flow, with more consistent year-over-year improvement.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has the edge over PDYN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
PDYN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.2% | +2.4M shares |
| 1 year | +19% | +7.9M shares |
| 3 years | +90% | +22.8M shares |
PDYN has 48M diluted shares, up 19% from a year ago.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PDYN Net Leverage
PDYN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
PDYN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.1 | Neutral |
| Stochastic | 8.3 | Oversold |
PDYN's weekly RSI is 32 (neutral) and its Stochastic is 8 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
PDYN PE vs Technology Sector
PDYN has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over PDYN on trend strength, trading above more of its moving averages.
PDYN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.10 | 21% below |
| 20 week MA | $5.03 | 36% below |
| 50 week MA | $5.84 | 45% below |
| 100 week MA | $6.82 | 52% below |
| 200 week MA | $4.34 | 25% below |
PDYN is in a downtrend: it's below all five of its weekly moving averages, and 25% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
PDYN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $44.0 | $57.1 | +30% |
| 2022 | $57.1 | $3.30 | -94% |
| 2023 | $3.30 | $0.72 | -78% |
| 2024 | $0.72 | $11.8 | +1535% |
| 2025 | $11.8 | $4.50 | -62% |
| 2026 YTD | $4.50 | $3.24 | -28% |
PDYN has the edge over ASTS on returns for 2026, with the stronger performance.